This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of INBRIJA 42 MG INHALATION CAP 60S medication. The $1,294.24 firm fixed price contract was awarded on December 19, 2024 by the Defense Logistics Agency (DLA), which is a component of the Department of Defense that specializes in supply chain management and the procurement of medical supplies. The contract has an ultimate completion date of January 13, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/20/25, 9:50 AM